
5 June 2025 @ 09:20
Blog: Computational Neoantigen Prediction: Unlocking Personalized Immunotherapy
How somatic variants are computationally translated into candidate neoantigens
5 June 2025 @ 09:20
How somatic variants are computationally translated into candidate neoantigens
12 September 2024 @ 15:27
Dr. Melissa Vrohlings, Translational Science Leader of CDR-Life, shares her experiences with our Virtual Bioinformatics Core service
15 August 2024 @ 10:24
Dr. Vibhu Sahni shares his experiences with our Virtual Bioinformatics Core service
29 April 2024 @ 15:24
Dr. Henri Huttunen from Herantis Pharma shares his experiences with our Virtual Bioinformatics Core service
13 December 2023 @ 15:00
Dr. Eric Feraille shares his experiences of our service
1 December 2023 @ 17:00
Dr. Rhoel Dinglasan shares his experiences of our Virtual Bioinformatics Core service
17 September 2023 @ 14:20
Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies
29 May 2023 @ 12:12
Learn how Professor Filgueira benefited from our transcriptomic data analysis service
13 March 2023 @ 09:54
We helped a researcher explore public data to study the biomarker and drug-targed potential of glypicans
6 March 2023 @ 13:18
Learn how a research group used our expertise to study the effects of cancer-predisposing variants
3 March 2023 @ 12:50
Learn how Amazentis leveraged omics analyses in a clinical trial for a postbiotic
4 November 2022 @ 14:49
Learn how RNA-seq and epigenomic data come together to reveal gene-regulatory programs
30 September 2022 @ 14:35
Presenting Dr. Flint, the winner of Genevia RNA-Seq Bioinformatics Grant 2022
8 February 2022 @ 13:54
Learn how Genevia Technologies helped Alimetrics uncover gene expression differences in an animal feed additive study.
9 June 2021 @ 14:28
Key points to keep in mind when interpreting results from an expression analysis
7 June 2021 @ 14:46
Learn how Genevia Technologies helped Barron Biomedical to identify a target for cancer therapy.
27 May 2021 @ 16:18
Learn how machine learning enables risk stratification using high-throughput data
17 March 2021 @ 16:26
Learn how Genevia Technologies helped with FastEV's commercialization.
2 March 2021 @ 19:50
Learn how Genevia Technologies helped MiNa TX with mechanism of action analysis.
25 April 2018 @ 13:47
When, if ever, is using microarrays better than RNA-seq?